# RTOG-0526 (NCT00450411)

> Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy

No report yet. It can be ordered.

- Drugs tested: none (the trial tests no drug)
- Indication: locally recurrent prostate cancer after external beam radiotherapy

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT00450411
- Phase: PHASE2
- Status: COMPLETED
- Sponsor: Radiation Therapy Oncology Group
- Conditions: Prostate Cancer
- Interventions: 125-Iodine; 103-palladium
- Enrollment: 100
- Primary outcome: Number of Patients With Late Treatment-related Gastrointestinal (GI) and Genitourinary (GU) Adverse Events (AE)

## Indexed commentary on RTOG-0526 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 9
- Podcasts: 1

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=rtog-0526-nct00450411

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT00450411", "email": "<work email>"}; the inbox owner confirms by the emailed link.